103 related articles for article (PubMed ID: 11351258)
1. Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.
Gariboldi MB; Ravizza R; Marras E; Perletti G; De Simone A; Piccinini F; Monti E
Int J Oncol; 2001 Jun; 18(6):1245-9. PubMed ID: 11351258
[TBL] [Abstract][Full Text] [Related]
2. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
4. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.
Takemura H; Urasaki Y; Yoshida A; Fukushima T; Ueda T
Cancer Res; 2001 Jan; 61(1):172-7. PubMed ID: 11196156
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
7. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation.
Whitman SP; Civoli F; Daniel LW
J Biol Chem; 1997 Sep; 272(38):23481-4. PubMed ID: 9295281
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
Guedez L; Suresh A; Tung F; Zucali J
Eur J Haematol; 1996 Aug; 57(2):149-56. PubMed ID: 8856092
[TBL] [Abstract][Full Text] [Related]
10. Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
Bullock G; Ray S; Reed JC; Krajewski S; Ibrado AM; Huang Y; Bhalla K
Leukemia; 1996 Nov; 10(11):1731-40. PubMed ID: 8892676
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
12. miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.
Bai H; Cao Z; Deng C; Zhou L; Wang C
J Cancer Res Clin Oncol; 2012 Apr; 138(4):595-602. PubMed ID: 22209977
[TBL] [Abstract][Full Text] [Related]
13. Effect of cytarabine and decitabine in combination in human leukemic cell lines.
Qin T; Youssef EM; Jelinek J; Chen R; Yang AS; Garcia-Manero G; Issa JP
Clin Cancer Res; 2007 Jul; 13(14):4225-32. PubMed ID: 17634552
[TBL] [Abstract][Full Text] [Related]
14. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
Bullock G; Ray S; Reed J; Miyashita T; Maria Ibrado A; Huang Y; Bhalla K
Clin Cancer Res; 1995 May; 1(5):559-64. PubMed ID: 9816016
[TBL] [Abstract][Full Text] [Related]
15. Combination of guanine arabinoside and Bcl-2 inhibitor YC137 overcomes the cytarabine resistance in HL-60 leukemia cell line.
Nishi R; Yamauchi T; Negoro E; Takemura H; Ueda T
Cancer Sci; 2013 Apr; 104(4):502-7. PubMed ID: 23320492
[TBL] [Abstract][Full Text] [Related]
16. [Effect of nimodipine on mechanisms of HL-60 cell apoptosis induced by cytarabine].
Sun LR; Gao BC; Pang XY; Lu Y; Li XR; Song AQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):72-5. PubMed ID: 17490525
[TBL] [Abstract][Full Text] [Related]
17. All-trans-retinoic acid increases cytosine arabinoside cytotoxicity in HL-60 human leukemia cells in spite of decreased cellular ara-CTP accumulation.
Freund A; Rössig C; Lanvers C; Gescher A; Hohenlöchter B; Jürgens H; Boos J
Ann Oncol; 1999 Mar; 10(3):335-8. PubMed ID: 10355579
[TBL] [Abstract][Full Text] [Related]
18. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
Lei XY; Zhang H; He DM
Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
[TBL] [Abstract][Full Text] [Related]
19. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
Li DL; Lu LH; Chen YY; Lin ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
[TBL] [Abstract][Full Text] [Related]
20. [Ara-c induced apoptosis in human myeloid leukemia cell line HL-60].
Zhou J; Chen Y; Li C
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):107-10. PubMed ID: 10743072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
